What is the recommended laser beam power for treating lower eyelid skin with an Alma (Aesthetic Laser and Light-based device) Fraxel (Fractional) CO2 (Carbon Dioxide) laser?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Laser Beam Power for Lower Eyelid Skin Treatment with Alma Fraxel CO2 Laser

For treating lower eyelid skin with an Alma fraxel CO2 laser, use pulse energy of 25-35 J with a pulse duration of 1 ms, 200 μm spot size, and a density of 100 laser spots/cm² per pass, with 1-3 passes depending on severity of photoaging. 1

Optimal Settings for Lower Eyelid Treatment

Power and Energy Settings

  • Pulse energy: 25-35 J
  • Pulse duration: 1 ms
  • Spot size: 200 μm
  • Density: 100 laser spots/cm² per pass 1
  • Number of passes: 1-3 (adjust based on desired skin contraction)

Important Modifications for Eyelid Skin

  • For delicate eyelid skin, reduce energy settings compared to other facial areas:
    • Use 250 mJ and 50 W for eyelid skin (compared to 300 mJ and 60 W used on other facial areas) 2
    • Lower settings are crucial to prevent excessive thermal damage to thin periorbital tissue

Treatment Protocol

Pre-treatment Considerations

  • Apply topical anesthesia before procedure 1
  • Maintain oxygen concentration below 40% to minimize fire risk 3
  • Keep a distance of at least 1 cm from target tissue to prevent charring 3

During Treatment

  • Use multiple-pass, low spot density technique for controlled skin contraction 1
  • Clean and debride tissue with normal saline between passes
  • Continuous suction to remove smoke is mandatory 3
  • Monitor skin contraction after each pass to determine if additional passes are needed 1

Post-treatment Care

  • Apply semi-occlusive dressing for the first 5 days after surgery 2
  • Follow with bland petrolatum ointment for an additional 5 days 2
  • Finally, use moisturizer with sunscreen or bleaching cream as needed 2

Expected Outcomes and Considerations

Efficacy

  • This protocol has demonstrated significant improvement in lower eyelid tightening:
    • 40% of patients achieved 50-75% improvement
    • 28% of patients achieved 75-100% improvement 1
  • Results show improvement in both skin laxity and photoaging

Safety Considerations

  • Potential complications include:
    • Transient erythema
    • Post-inflammatory hyperpigmentation (more common in darker skin types)
    • Rare instances of hypertrophic scarring 4
    • Risk of ectropion (6.25%) if settings are too aggressive 5

Clinical Pearls

  • Control skin contraction: The fractional CO2 delivery allows immediate control of skin contraction during the procedure by adjusting the number of passes 1
  • Avoid overtreatment: Using high energy with lower laser spot density provides better control than high density with lower energy
  • Eyelid-specific caution: The thin skin of the lower eyelid requires reduced settings compared to other facial areas to prevent complications 2
  • Monitor healing: Delayed epithelial healing may occur with certain underlying conditions 6
  • Consider alternatives: For patients with significant skin laxity, transcutaneous blepharoplasty may be preferable to laser resurfacing alone 5

This protocol provides an effective balance between achieving significant skin tightening and photoaging improvement while minimizing recovery time and complications when treating the delicate lower eyelid area.

References

Research

Complications of laser resurfacing. Methods of prevention and management.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1998

Guideline

CO2 Laser Applications in Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.